Relationship between diffusion-weighted magnetic resonance imaging and histological tumor grading of hepatocellular carcinoma

Annals of Surgical Oncology

Volumn 19, Issue 4, 2012, Pages 1302-1309

  Nakanishi, Mitsuru ^a   Chuma, Makoto ^a   Hige, Shuhei ^a   Omatsu, Tokuhiko ^b   Yokoo, Hideki ^a   Nakanishi, Kazuaki ^a   Kamiyama, Toshiya ^a   Kubota, Kanako ^a   Haga, Hironori ^a   Matsuno, Yoshihiro ^a   Onodera, Yuya ^a   Kato, Mototsugu ^a   Asaka, Masahiro ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER PATIENT; CANCER RECURRENCE; CLINICAL ARTICLE; DIFFUSION WEIGHTED IMAGING; FEMALE; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER RESECTION; MALE; RETROSPECTIVE STUDY; RISK FACTOR;

AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; RETROSPECTIVE STUDIES;

EID: 84861871427     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-011-2066-8     Document Type: Article

References (31)

1. Kiyosawa K, Uemura T, Ichijo T, Matsumoto A, Yoshizawa K, Gad A, et al. Hepatocellular carcinoma: recent trends in Japan. Gastroenterology. 2004;127:S17-S26. (Pubitemid 39423366)
2. Park JH, Koh KC, Choi MS, Lee JH, Yoo BC, Paik SW, et al. Analysis of risk factors associated with early multinodular recurrences after hepatic resection for hepatocellular carcinoma. Am J Surg. 2006;192:29-33. (Pubitemid 43849602)
3. Portolani N, Coniglio A, Ghidoni S, Giovanelli M, Benetti A, Tiberio GA, et al. Early and late recurrence after liver resection for hepatocellular carcinoma. Ann Surg. 2006;243: 229-35.
4. Llovet JM, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology. 1999;30:1434-40.
5. Roayaie S, Blume IN, Thung SN, Guido M, Fiel MI, Hiotis S, et al. A system of microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma. Gastroenterology. 2009;137:786-8.
6. Imamura H, Matsuyama Y, Tanaka E, Ohkubo T, Hasegawa K, Miyagawa S, et al. Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol. 2003;38:200-7. (Pubitemid 36169630)
7. Regimbeau JM, Abdalla EK, Vauyhey JN, Lauwers GY, Durand F, Nagorney DM, et al. Risk factors for early death due to recurrence after liver resection for hepatocellular carcinoma: result of a multicenter study. J Surg Oncol. 2004;85:36-41. (Pubitemid 38036738)
8. Capussotti L, Muratore A, Amisano M, Polastri R, Bouzari H, Massucco P. Liver resection for hepatocellular carcinoma on cirrhosis: analysis of mortality, mobility and survival - a European single center experience. Eur J Surg Oncol. 2005;31: 986-93. (Pubitemid 41671112)
9. Ng KK, Vauthey JN, Pawlik TM, Lauwers GY, Regimbeau JM, Belghiti J, et al. Is hepatic resection for large or multinodular hepatocellular carcinoma justified? Results from multi-institutional data base. Ann Surg Oncol. 2005:12;364-73.
10. Peng SY, Chen WJ, Lai PL, Jeng YM, Sheu JC, Hsu HC. High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations. Int J Cancer. 2004;112:44-50. (Pubitemid 39249490)
11. Stevens WR, Johnson CD, Stephens DH, Batts KP. CT findings in hepatocellular carcinoma: correlation of tumor characteristics with causative factors, tumor size, and histologic tumor grade. Radiology. 1994;191:531-7. (Pubitemid 24141063)
12. Hayashi M, Matsui O, Ueda K, Kawamori Y, Kadoya M, Yoshikawa J, et al. Correlation between the blood supply and grade of malignancy of hepatocellular nodules associated with liver cirrhosis: evaluation by CT during intraarterial injection of contrast medium. Am J Roentgenol. 1999;172:969-76. (Pubitemid 29505622)
13. Jang HG, Kim TK, Burns PN, Wilson SR. Enhancement patterns of hepatocellular carcinoma at contrast-enhanced US: comparison with histologic differentiation. Radiology. 2007;244:898-906. (Pubitemid 47292103)
14. Bulakbasi IM, Kocaoglu M, Ors F, Tayfun C, Uçöz T. Combination of single-voxel proton MR spectroscopy and apparent diffusion coefficient calculation in evaluation of common brain tumors. Am J Neuroradiol. 2003;24:225-33. (Pubitemid 36237173)
15. Higano S, Yun X, Kumabe T, Watanabe M, Mugikura S, Umetsu A, et al. Malignant astrocytic tumors: clinical importance of apparent diffusion coefficient in prediction of grade and prognosis. Radiology. 2006;241:839-46. (Pubitemid 46190551)
16. Dow-Mu K, David JC. Diffusion-weighted MRI in the body: Applications and challenges in oncology. Am J Roentgenol. 2007;188:1622-35.
17. Colagrande S, Carbone SF, Carusi LM, Cova M, Villari N. Magnetic resonance diffusion-weighted imaging: extraneurological applications. Radiol Med. 2006;111:392-419.
18. Chen YC, Li CW, Kuo YT, Jaw TS, Wu DK, Jao JC, et al. Early response of hepatocellular carcinoma to transcatheter arterial chemoembolization: choline levels and MR diffusion constants - initial experience. Radiology. 2006;239:448-456.
19. Nishie A, Tajima T, Asayama Y, Ishigami K, Kakihara D, Nakayama T, et al. Diagnostic performance of apparent coefficient for predicting histological grade of hepatocellular carcinoma. Eur J Radiol. doi:10.1016/j.ejrad.201.06.019 [Epub ahead of print].
20. Heo SH, Jeong YY, Shin SS, Kim JW, Lim HS, Lee JH, et al. Apparent diffusion coefficient value of diffusion-weighted imaging for hepatocellular carcinoma: correlation with histologic differentiation and the expression of vascular endothelial growth factor. Korean J Radiol. 2010;11:295-303.
21. Nasu K, Kuroki Y, Tsukamoto T, Nakajima H, Mori K, Minami M, et al. Diffusion-weighted imaging of surgically resected hepatocellular carcinoma: imaging characteristics and relationship among signal intensity, apparent diffusion coefficient, and histopathologic grade. Am J Roentgenol. 2009;193:438-44.
22. Bruix J, Sherman. Management of hepatocellular carcinoma. Hepatology. 2005;42:1208-36.
23. International Working Party. Terminology of nodular hepatocellular lesions. Hepatology. 1995 22:983-93.
24. Guo Y, Cai YQ, Cai ZL, Gao YG, An NY, Ma L, et al. Differentiation of clinically benign and malignant breast lesions using diffusion-weighted imaging. J Magn Reson Imaging. 2002;16:172-8. (Pubitemid 34810055)
25. Guo AC, Cummings TJ, Dash RC, Provenzale JM. Lymphomas and high-grade astrocytomas: comparison of water diffusibility and histologic characteristics. Radiology. 2002;224:177-83. (Pubitemid 34680392)
26. Calvar JA, Meli FJ, Romero C, Calcagno ML, Yanez P, Martinez AR, et al. Characterization of brain tumors by MRS, DWI and Ki-67 labeling index. J Neurooncol. 2005;72:273-80. (Pubitemid 40867413)
27. Taouli B, Vilgrain V, Dumont E, Daire JL, Fan B, Menu Y. Evaluation of liver diffusion isotropy and characterization of focal hepatic lesions with two single-shot echo-planar MR imaging sequences. Radiology. 2003;226:71-8. (Pubitemid 36163910)
28. Lewin M, Poujol-Robert A, Boelle PY, Wendum D, Lasnier E, Viallon M, et al. Diffusion-weighted magnetic resonance imaging for the assessment of fibrosis in chronic hepatitis C. Hepatology. 2007;46:658-65. (Pubitemid 47436110)
29. Kamel IR, Bluemke DA, Ramsey D, Abusedera M, Torbenson M, Eng J, et al. Role of diffusion-weighted imaging in estimating tumor necrosis after chemoembolization of hepatocellular carcinoma. Am J Roentgenol. 2003;181:708-10. (Pubitemid 37021839)
30. Park JH, Koh KC, Choi MS, Lee JH, Yoo BC, Paik SW, et al. Analysis of risk factors associated with early multinodular recurrences after hepatic resection for hepatocellular carcinoma. Am J Surg. 2006;192:29-33. (Pubitemid 43849602)
31. Miller LC, Thrall JF. Clinical molecular imaging. J Am Coll Radiol. 2004;1:4-23.